Abstract
Background Serotype specific estimates of pneumococcal invasiveness used in pneumococcal carriage transmission models to predict changes in disease incidence post vaccination are largely derived from high income settings. We conducted a systematic review of carriage prevalence and invasive pneumococcal disease (IPD) incidence to calculate case-carrier ratios (CCRs) in different income settings. Methods A systematic search of Medline, Embase, and Global Health databases in March 2022 identified publications on pneumococcal carriage prevalence or IPD incidence; we requested individual-level data from authors of relevant texts. Serotype-specific CCRs, calculated as IPD incidence divided by carriage prevalence, were pooled across settings using random effects meta-analyses, stratified by pre/post pneumococcal conjugate vaccine (PCV) introduction, country income group, age-group, sex and HIV status. Findings We identified 80 publications from 18 countries (13 upper middle or high income countries (UM/HIC), 5 low/lower middle income (L/LMIC)) reporting carriage prevalence or IPD incidence in overlapping geographical areas, time periods, and age groups. We calculated CCRs for >70 serotypes, stratified by age group, income settings, and pre and post vaccine introduction. In children under five, pre PCV CCRs for serotypes not included in the 20 valent PCV were higher in L/LMICs than UM/HICs, 152 (95% Confidence interval 103-226) versus 102 (50-209). Post PCV CCRs for nonvaccine serotypes dropped in UM/HICs but not in L/LMICs, 19 (16-22) versus 154 (119-200) respectively. Pre/post PCV changes varied by serotype and agegroup. CCRs were lowest in 5 to 14 year olds and were higher in HIV positive than HIV negative individuals. There were no differences in CCRs by sex. Interpretation Pneumococcal invasiveness varies by serotype, age-group, country income-group, HIV status and over time; however, substantial variation remained unexplained. Our CCRs represent the most representative estimates of invasiveness currently available for use in statistical or mathematical prediction models of disease incidence, where only carriage prevalence data are available. Funding: The Wellcome Trust, Great Britain (098532)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: The Wellcome Trust, Great Britain (098532)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research Ethics committee of the London School of Hygiene & Tropical Medicine gave ethical approval for this work (Ref: 27394). This activity was reviewed by CDC, deemed not research, and waived of the need for ethical approval. The study was conducted consistent with applicable federal law and CDC policy.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos